Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01370538 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Esomeprazole in Patients With Frequent Heartburn
A Phase 3 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 3
- Development phase
- 341
- Enrollment target
NCT01370538 is a Phase 3 study that has completed, run by AstraZeneca. The registered enrollment target is 341 participants.
The verdict
NCT01370538, a Phase 3 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 341 participants
- Enrollment target
Study Summary
This study will investigate the efficacy of esomeprazole 20 mg once a day in the treatment of frequent heartburn
Interventions
- DRUG Esomeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01370538
The ClinicalTrials.gov registry entry for NCT01370538 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 341 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Esomeprazole is the first listed.
NCT01370538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01370538 about?
NCT01370538 is a clinical study titled "Efficacy of Esomeprazole in Patients With Frequent Heartburn". This study will investigate the efficacy of esomeprazole 20 mg once a day in the treatment of frequent heartburn
What is the current status of trial NCT01370538?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 341 participants. The study started on 2011-08. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01370538?
The interventions under investigation include: Esomeprazole (DRUG).
Who is sponsoring clinical trial NCT01370538?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.